Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2020 Jun 19;182(3):665–677. doi: 10.1007/s10549-020-05714-2

Fig. 2-. Plasma DNA sequencing identifies proportions of stem and non-stem mutations.

Fig. 2-

A) Proportions of stem mutations (found in all tumors) versus non-stem mutations (found in at least one but not all tumors) are shown for each patient. B/C) Proportions of non-stem (private/clade) (B) and stem (C) mutations identified in plasma DNA are shown.